Healthcare Services company Dr. Lal Pathlabs announced Q1FY25 results:
- Revenue increased by 11.3% in Q1FY25 to Rs 602 crore
- EBITDA increased by 16.2% with a margin of 28.2%
- PAT increased by 29.1% to Rs 108 crore with a margin for of 17.9%
- Interim Dividend of Rs 6 per share for FY 2024-25